Sphera Funds Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Sphera Funds Management’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-185,000	Closed	-$1.4M	–	135
2018 Q4	$1.4M	Buy	185,000 +65,000	+54%	+$1.05M	0.16%	83
2018 Q3	$2.52M	Buy	+120,000	New	+$2.86M	0.29%	80
2017 Q4	–	Sell	-78,284	Closed	-$1.9M	–	161
2017 Q3	$1.9M	Sell	78,284 -16,716	-18%	-$396K	0.27%	88
2017 Q2	$2.12M	Buy	+95,000	New	+$2M	0.36%	81

Other funds holding DOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sphera Funds Management's DOVA Position: Q1 2019 in Review

Sphera Funds Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q1 2019, closing a stake of 185,000 shares — an estimated $1.4M sold.

Sphera Funds Management first reported a position in DOVA in Q2 2017 and held it in 4 quarters. The position peaked at $2.52M in Q3 2018. 59 funds tracked by Wall St. Rank hold DOVA as of Q1 2019.

Sphera Funds Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Sphera Funds Management sold 185,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $1.4M.
Sphera Funds Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 4 quarters.
Sphera Funds Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $2.52M in Q3 2018.
59 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.